360Dx — Proteomics International Laboratories Transfers Diabetic Kidney Disease Test Tech to Atturos
“NEW YORK — Proteomics International Laboratories said on Thursday that it has completed the...
Proteomics International signs deal to launch PromarkerD test for diabetic kidney disease in USA
Proteomics International Ltd (Proteomics International; ASX: PIQ) has signed the first licence agreement for its world-leading PromarkerD predictive test for diabetic kidney disease in the United States, creating a partnership with US-based precision medicine and diagnostic services laboratory PrismHealthDx, Inc. (PHDx).